Literature DB >> 31819596

Prediction Of Serum Digoxin Concentration Using Estimated Glomerular Filtration Rate In Thai Population.

Orawan Sae-Lim1, Thitima Doungngern1, Siriluk Jaisue2, Sirichai Cheewatanakornkul3, Poukwan Arunmanakul4, Sirirat Anutrakulchai5, Rungsrit Kanjanavanit6, Wibul Wongpoowarak7.   

Abstract

PURPOSE: Serum digoxin concentration (SDC) monitoring may be unavailable in some healthcare settings. Predicted SDC comes into play in the efficacy and toxicity monitoring of digoxin. Renal function is the important parameter for predicting SDC. This study was conducted to compare measured and predicted SDC when using creatinine clearance (CrCl) from Cockcroft-Gault (CG) equation and estimated glomerular filtration rate (eGFR) calculated from CKD-Epidemiology Collaboration (CKD-EPI), re-expressed Modification of Diet in Renal Disease (Re-MDRD4), Thai-MDRD4, and Thai-eGFR equations in Sheiner's and Konishi's pharmacokinetic models. PATIENTS AND METHODS: In this retrospective study, patients with cardiovascular disease with a steady-state of SDC within 0.5-2.0 mcg/L were enrolled. CrCl and studied eGFR adjusted for body surface area (BSA) were used in the models to determine the predicted SDC. The discrepancies of the measured and the predicted SDC were analyzed and compared.
RESULTS: One hundred and twenty-four patients ranging in age from 22 to 88 years (median 60 years, IQR 50.2, 69.2) were studied. Their serum creatinine ranged from 0.40 to 1.80 mg/dL (median 0.90 mg/dL, IQR 0.79, 1.10). The mean±SD of measured SDC was 1.12±0.34 mcg/L. In the Sheiner's model, the mean predicted SDC was calculated by using the CG and the BSA adjusted CKD-EPI equations and was not different when compared with the measured levels (1.10±0.36 mcg/L (p=0.669) and 1.08±0.42 mcg/L (p=0.374), respectively). The CG, CKD-EPI, and Re-MDRD4 equations were a better fit for patients with creatinine ≥0.9 mg/dL for prediction with minimal errors. In the Konishi's model, the predicted SDC using the CG and the studied eGFR equation was lower than the measured SDC (p<0.05).
CONCLUSION: In Sheiner's model, the CG and the BSA adjusted CKD-EPI equations should be used for predicting SDC, especially in patients with serum creatinine ≥0.9 mg/dL. The other studied eGFRs underestimated SDC in both Sheiner's and Konishi's model.
© 2019 Sae-lim et al.

Entities:  

Keywords:  Cockcroft–Gault equation; creatinine clearance; digoxin; estimated glomerular filtration rate equation; predicted concentration

Year:  2019        PMID: 31819596      PMCID: PMC6896919          DOI: 10.2147/IJGM.S218393

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  21 in total

Review 1.  Digoxin in the management of cardiovascular disorders.

Authors:  Mihai Gheorghiade; Kirkwood F Adams; Wilson S Colucci
Journal:  Circulation       Date:  2004-06-22       Impact factor: 29.690

2.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Kianoush Kashani
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

4.  Can available mathematical models predict serum digoxin levels in Thai patients?

Authors:  J Jiratham-Opas; R Kanjanavanit; W Wongcharoen; B Punyawudho; P Arunmanakul; A Amaritakomol; P Topaiboon; S Gunaparn; A Phrommintikul
Journal:  J Clin Pharm Ther       Date:  2018-01-24       Impact factor: 2.512

5.  Digoxin and Mortality in Patients With Atrial Fibrillation.

Authors:  Renato D Lopes; Roberto Rordorf; Gaetano M De Ferrari; Sergio Leonardi; Laine Thomas; Daniel M Wojdyla; Peter Ridefelt; John H Lawrence; Raffaele De Caterina; Dragos Vinereanu; Michael Hanna; Greg Flaker; Sana M Al-Khatib; Stefan H Hohnloser; John H Alexander; Christopher B Granger; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2018-03-13       Impact factor: 24.094

6.  The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations.

Authors:  Kearkiat Praditpornsilpa; Natavudh Townamchai; Tawatchai Chaiwatanarat; Khajohn Tiranathanagul; Pisut Katawatin; Paweena Susantitaphong; Thananda Trakarnvanich; Talerngsak Kanjanabuch; Yingyos Avihingsanon; Kriang Tungsanga; Somchai Eiam-Ong
Journal:  Nephrol Dial Transplant       Date:  2011-02-28       Impact factor: 5.992

7.  A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.

Authors:  Eun Jung Park; Kunyi Wu; Zenghui Mi; Ting Dong; John P Lawrence; Chia-Wen Ko; Shiew-Mei Huang; Lei Zhang; Victor Crentsil; Jialu Zhang; Nancy N Xu
Journal:  Ann Pharmacother       Date:  2012-08-28       Impact factor: 3.154

8.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

9.  Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients.

Authors:  Aghogho A Okparavero; Hocine Tighiouart; Zipporah Krishnasami; Christina M Wyatt; Hiba Graham; James Hellinger; Lesley A Inker
Journal:  Antivir Ther       Date:  2013-08-20

10.  Glomerular filtration rate estimation using the Cockcroft-Gault and modification of diet in renal disease formulas for digoxin dose adjustment in patients with heart failure.

Authors:  Marta Vazquez-Hernandez; Lorena Bouzas; J Carlos Tutor
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.